Related Experiment Video
Updated: May 9, 2026

Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders
Published on: February 3, 2021
Berberine behind the thriller of marked symptomatic bradycardia
Margherita Cannillo1, Simone Frea, Cristina Fornengo
1Margherita Cannillo, Simone Frea, Cristina Fornengo, Elisabetta Toso, Fiorenzo Gaita, Division of Cardiology, Cardiovascular Department, AOU S. Giovanni Battista di Torino and University of Torino, 10100 Torino, Italy.
Insights
Berberine, a traditional Chinese medicine, can cause serious heart rhythm issues like bradycardia and arrhythmias in hypervagotonic individuals. Careful consideration of berberine use is advised for these patients.
Area of Science:
- Cardiology
- Pharmacology
- Traditional Chinese Medicine
Background:
- Berberine is a compound used in Traditional Chinese Medicine for various conditions, including cardiovascular diseases.
- It is generally considered to have a good safety profile.
- Hypervagotonia, a state of increased parasympathetic nervous system activity, can predispose individuals to certain cardiovascular events.
Purpose of the Study:
- To report a case of adverse cardiovascular effects associated with berberine use.
- To investigate the potential proarrhythmic effects of berberine in individuals with a hypervagotonic state.
- To highlight the importance of considering patient-specific factors when prescribing berberine.
Main Methods:
- A case report of a 53-year-old male experiencing fatigue and dyspnea after initiating berberine for hypercholesterolemia.
- Electrocardiogram (ECG) and ergometric stress testing were performed.
- A 10-day berberine washout period was implemented, followed by repeat testing and Holter monitoring.
Main Results:
- Initial ECG revealed sinus bradycardia, atrioventricular block, and junctional rhythm.
- Stress testing showed reduced chronotropic competence and arrhythmias.
- After berberine cessation, symptoms resolved, stress test normalized, and Holter monitoring indicated a latent hypervagotonic state.
Conclusions:
- This case suggests berberine can induce bradycardic and antiarrhythmic effects that may become proarrhythmic in hypervagotonic individuals.
- The drug's use warrants caution in patients with a hypervagotonic state, even without conditions promoting drug accumulation.
- This highlights the need for personalized risk assessment when using berberine.
Abstract:
Patients with chronic aortic dissections are at high risk of catheter-induced complications. We report a Berberine is used in traditional Chinese medicine for the treatment of congestive heart failure, hypertension, diabetes, and dyslipidaemia and has a good safety profile. We report a case of a 53-year-old sportsman referred to our hospital for the onset of fatigue and dyspnoea upon exertion after he started berberine to treat hypercholesterolaemia. An electrocardiogram showed sinus bradycardia (45 bpm), first-degree atrioventricular block, and competitive junctional rhythm. An ergometric stress test showed slightly reduced chronotropic competence and the presence of runs of competitive junctional rhythm, atrial tachycardia, and sinus pauses in the recovery. After 10 d of wash-out from berberine, the patient experienced a complete resolution of symptoms, and an ergometric stress test showed good chronotropic competence. An electrocardiogram Holter showed a latent hypervagotonic state. This is the first case report that shows that berberine could present certain side effects in hypervagotonic people, even in the absence of a situation that could cause drug accumulation. Therefore, berberine's use should be carefully weighed in hypervagotonic people due to the drug's bradycardic and antiarrhythmic properties, which could became proarrhythmic, exposing patients to potential health risks.
Related Concept Videos
Decreased pulse rate
There are specific risk factors that can elevate the likelihood of developing bradycardia. Advanced age is a significant factor, with bradycardia...
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Dysrhythmias IV: Characteristics of Bradyarrhythmias
Heart Failure Drugs: β-Blockers
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...

